4-phenylenediamine has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cance, W; Dunn, KM; Golubovskaya, VM; Heffler, M | 1 |
1 other study(ies) available for 4-phenylenediamine and Colonic Neoplasms
Article | Year |
---|---|
Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Focal Adhesion Protein-Tyrosine Kinases; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phenylenediamines; Phosphorylation; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays | 2013 |